Satsuma Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Two
Satsuma Pharmaceuticals, Inc. had Long-Term Debt, Maturity, Year Two of $833.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2021-03-25
- 2020-12-31: Long-Term Debt, Maturity, Year Two $833.00K.
- 2020-09-30: Long-Term Debt, Maturity, Year Two $833.00K.
- 2020-06-30: Long-Term Debt, Maturity, Year Two $833.00K.
- 2020-03-31: Long-Term Debt, Maturity, Year Two $2.00M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2020-12-31 | $833.00K 10-K · filed 2021-03-25 |
| 2020-09-30 | $833.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $833.00K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $2.00M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $2.00M 10-K · filed 2020-03-10 |
| 2019-09-30 | $2.00M 10-Q · filed 2019-11-12 |